Skip to main content

DSM Leads Sequencing of Aspergillus niger Genome

NEW YORK (GenomeWeb News) - Dutch industrial chemical firm DSM has completed a collaborative project to sequence the genome of Aspergillus niger CBS 513.88, a microorganism that DSM uses to produce enzymes and other compounds.
 
DSM and its collaborators are publishing the results of the sequencing project in the February issue of Nature Biotechnology. DSM said 29 other research institutions participated in the study.
 
The A. niger genome has around 33.9 million base pairs with more than 14,000 unique genes. The functions of as many as 6,500 of these genes may be discovered, the company said.
 
The project has so far spurred “numerous” DSM patent applications, DSM said, including products such as one for muscular recovery, an enzyme to prevent ‘chill-haze’ in beer, and an enzyme to prevent formation of a toxic compound in some fried foods.
 
The company said the project resulted in several new collaborations with companies such as Gene Alliance, Biomax, Affymetrix, the University of Amsterdam, and others.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.